Exchange Traded Concepts LLC bought a new stake in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report) in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 47,782 shares of the real estate investment trust's stock, valued at approximately $835,000.
A number of other institutional investors and hedge funds also recently made changes to their positions in the company. Wealth Enhancement Advisory Services LLC purchased a new position in shares of Sabra Healthcare REIT in the 1st quarter valued at approximately $180,000. Fifth Third Bancorp lifted its stake in shares of Sabra Healthcare REIT by 110.3% in the 1st quarter. Fifth Third Bancorp now owns 3,835 shares of the real estate investment trust's stock valued at $67,000 after purchasing an additional 2,011 shares during the period. SG Americas Securities LLC lifted its stake in shares of Sabra Healthcare REIT by 7.5% in the 1st quarter. SG Americas Securities LLC now owns 23,588 shares of the real estate investment trust's stock valued at $412,000 after purchasing an additional 1,647 shares during the period. Harbor Capital Advisors Inc. lifted its stake in shares of Sabra Healthcare REIT by 17.2% in the 1st quarter. Harbor Capital Advisors Inc. now owns 4,377 shares of the real estate investment trust's stock valued at $76,000 after purchasing an additional 642 shares during the period. Finally, UMB Bank n.a. lifted its stake in shares of Sabra Healthcare REIT by 379.6% in the 1st quarter. UMB Bank n.a. now owns 2,048 shares of the real estate investment trust's stock valued at $36,000 after purchasing an additional 1,621 shares during the period. Hedge funds and other institutional investors own 99.40% of the company's stock.
Analyst Ratings Changes
SBRA has been the subject of a number of analyst reports. Truist Financial raised their price objective on Sabra Healthcare REIT from $17.00 to $18.00 and gave the company a "hold" rating in a research report on Tuesday, March 18th. Scotiabank raised their price objective on Sabra Healthcare REIT from $19.00 to $20.00 and gave the company a "sector perform" rating in a research report on Monday. Three research analysts have rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, Sabra Healthcare REIT has an average rating of "Moderate Buy" and a consensus price target of $19.67.
Read Our Latest Report on SBRA
Sabra Healthcare REIT Stock Up 1.9%
Shares of Sabra Healthcare REIT stock traded up $0.34 on Monday, reaching $18.59. The company's stock had a trading volume of 2,189,198 shares, compared to its average volume of 2,288,281. The company has a market capitalization of $4.42 billion, a price-to-earnings ratio of 31.51, a P/E/G ratio of 1.38 and a beta of 0.85. The firm's fifty day simple moving average is $17.80 and its two-hundred day simple moving average is $17.26. Sabra Healthcare REIT, Inc. has a 52 week low of $14.63 and a 52 week high of $20.03. The company has a quick ratio of 4.22, a current ratio of 4.22 and a debt-to-equity ratio of 0.89.
Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last posted its earnings results on Monday, May 5th. The real estate investment trust reported $0.37 EPS for the quarter, topping analysts' consensus estimates of $0.36 by $0.01. The business had revenue of $183.54 million during the quarter, compared to analyst estimates of $180.23 million. Sabra Healthcare REIT had a return on equity of 5.14% and a net margin of 19.55%. The company's quarterly revenue was up 10.1% compared to the same quarter last year. During the same quarter last year, the company earned $0.35 EPS. Equities analysts anticipate that Sabra Healthcare REIT, Inc. will post 1.45 earnings per share for the current year.
Sabra Healthcare REIT Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Friday, May 30th. Shareholders of record on Friday, May 16th were issued a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a dividend yield of 6.46%. The ex-dividend date was Friday, May 16th. Sabra Healthcare REIT's payout ratio is 203.39%.
Insiders Place Their Bets
In other news, Director Michael J. Foster sold 11,000 shares of the firm's stock in a transaction on Tuesday, May 20th. The stock was sold at an average price of $18.22, for a total value of $200,420.00. Following the transaction, the director now directly owns 64,725 shares in the company, valued at $1,179,289.50. This trade represents a 14.53% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link. Corporate insiders own 1.10% of the company's stock.
About Sabra Healthcare REIT
(
Free Report)
Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.
See Also
Before you consider Sabra Healthcare REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sabra Healthcare REIT wasn't on the list.
While Sabra Healthcare REIT currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
